Tower Research Capital LLC (TRC) - SELECTA BIOSCIENCES INC ownership

SELECTA BIOSCIENCES INC's ticker is SELB and the CUSIP is 816212104. A total of 80 filers reported holding SELECTA BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 8.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SELECTA BIOSCIENCES INC
ValueSharesWeighting
Q1 2024$4,640
-50.7%
7,138
-47.8%
0.00%
Q4 2023$9,414
-22.1%
13,664
+19.9%
0.00%
Q3 2023$12,082
-10.5%
11,398
-5.4%
0.00%
Q2 2023$13,501
+43451.6%
12,054
-46.3%
0.00%
-100.0%
Q1 2023$31
-39.2%
22,451
-50.4%
0.00%
-50.0%
Q4 2022$51
-100.0%
45,291
-27.7%
0.00%0.0%
Q3 2022$102,000
+70.0%
62,624
+36.6%
0.00%
+100.0%
Q2 2022$60,000
-43.4%
45,831
-46.6%
0.00%0.0%
Q1 2022$106,000
+158.5%
85,808
+590.4%
0.00%0.0%
Q4 2021$41,000
-39.7%
12,428
-24.3%
0.00%
-50.0%
Q3 2021$68,000
+38.8%
16,428
+40.1%
0.00%
+100.0%
Q2 2021$49,000
-32.9%
11,727
-27.0%
0.00%0.0%
Q1 2021$73,000
-50.3%
16,072
-66.8%
0.00%
-75.0%
Q4 2020$147,000
-9.8%
48,361
-26.3%
0.00%
+100.0%
Q3 2020$163,000
+1530.0%
65,624
+1845.0%
0.00%
Q2 2020$10,000
-65.5%
3,374
-72.2%
0.00%
-100.0%
Q4 2019$29,00012,151
+17769.1%
0.00%
Q3 2019$0
-100.0%
68
-98.1%
0.00%
Q2 2019$7,000
-79.4%
3,539
-71.7%
0.00%
-100.0%
Q4 2018$34,000
-2.9%
12,504
+463.5%
0.00%
-33.3%
Q3 2018$35,000
+3400.0%
2,219
+5739.5%
0.00%
Q2 2018$1,000
-75.0%
38
-90.8%
0.00%
Q1 2018$4,000
-88.2%
412
-88.0%
0.00%
-100.0%
Q4 2017$34,000
-8.1%
3,435
+66.6%
0.00%
+33.3%
Q3 2017$37,000
-26.0%
2,062
-17.1%
0.00%
-50.0%
Q2 2017$50,000
+455.6%
2,486
+357.8%
0.01%
+500.0%
Q4 2016$9,000
+50.0%
543
+30.8%
0.00%0.0%
Q3 2016$6,0004150.00%
Other shareholders
SELECTA BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,924,151$32,999,00039.17%
Flagship Pioneering Inc. 826,862$14,181,0004.61%
Silver Rock Financial LP 461,076$7,907,0003.52%
SPHERA FUNDS MANAGEMENT LTD. 268,534$4,605,0001.17%
HAMILTON LANE ADVISORS LLC 74,833$1,283,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 853,205$14,632,0000.60%
Orbimed Advisors 1,842,797$31,604,0000.40%
Perceptive Advisors 141,875$2,433,0000.17%
HILLMAN CO 16,932$290,0000.10%
Baker Brothers Advisors 175,712$3,013,0000.03%
View complete list of SELECTA BIOSCIENCES INC shareholders